|
|
 |
|
Viewing report
|
|
|
|
Best Practices for Internal Communications Regarding Brands & Disease States
Best Practices LLC, July 2009, Pages: 62
This benchmarking study, based on benchmark survey data and executive interviews of 45 participants from more than 34 leading pharmaceutical, biotechnology and medical device companies, was conducted to examines the programs and initiatives aimed at directly affecting the lives and treatment of patients. This report provides benchmarks, insights and best practices in such key areas as:
- Gaining insights into the current landscape and the future of these patient-focused initiatives
- Describing the rationale and objectives of these efforts
- Defining the conditions and measures of success
- Understanding the potential pitfalls and limitations of such efforts
- Collecting examples and develop “case study” snapshots of innovative programs and initiatives
With so much riding on the consumers’ acceptance of a product, it is only logical to have in place initiatives that focus on the unfulfilled needs of the consumer population when designing marketing strategies.
The benefits of consumer acceptance can span from the establishment of name recognition/distinction and reputation to the generation and retention of patient referrals.
Earning this reputation in the market helps to engender pride and trust not only amongst staff, but amongst the various stakeholders within the community as well. It is the acceptance of the consumers that will, ultimately, have the greatest effect on a product’s success in the market, thus spurring the revenue generated by a product.
As pharmaceutical, biotechnology and medical device companies seek new “go-to-market” strategies and tactics, they have explored new ways to approach and engage patient populations. This benchmarking report examines the programs and initiatives aimed at directly affecting the lives and treatment of patients.
Industries Profiled:
- Biotech
- Pharmaceutical
- Consumer Products
- Diagnostic
- Health Care
- Research
- Technology
- Manufacturing
- Telecommunications
KEY FINDINGS:
The following are select key findings from the report executive summary.
- Patient-focused work is largely experimental and somewhat suspect
- Pockets of effort are in the early stages
- Traditional pharma perspectives “frown on” such activities
- Efforts are often focused on relatively small target populations
- Allows engagement at an individual level
- Keeps costs down
- Commercial elements are muted
- Patient benefits and healthcare outcomes are in foreground
- Public health benefits overshadow focus on commercial gain
- Alignment with patient outcomes offers alternative measures of success'
Customers who bought this item also bought
Patient Education and Direct-to-Patient Communication
Designing Patient Communications Programs: Education, Adherence, and Disease Management
Reinventing Patient Recruitment
Patient Empowerment: empowered patients can change healthcare outcomes and impact the pharmaceutical industry
Improving Patient Engagement in Telephonic and Online Health Improvement Programs for Lasting Behavior Change Webinar on CD-ROM
Patient Monitoring Markets
Online Patient Recruitment And Its Impact On Patient Relationship Management
Beyond Disease Management: Strategies for Improving Patient Care and Cutting Costs
Stakeholder Insight: Patient Compliance in Psychiatry - From Patient Acquisition to Patient Retention
eHealth Solutions for Pharma: Strategies for Salesforces, Marketing, Patient Compliance and Clinical Trials
Patient Self-Monitoring: Markets and Opportunities
Patient Scales - Global Strategic Business Report
|
|
|
|
